<DOC>
	<DOCNO>NCT01482702</DOCNO>
	<brief_summary>Obesity epidemic majority breast cancer survivor overweight obese . The American Cancer Society call weight loss treatment standard care overweight woman breast cancer . During therapy woman breast cancer often gain weight lose lean muscle mass . Overweight breast cancer survivor likely cancer come back . The reason overweight breast cancer survivor likely re-occur well study , change insulin work may contribute . Overweight survivor also risk chronic disease associate obesity . Fortunately , weight loss little 5-7 % baseline body weight improve risk chronic disease . An effective behaviorally-based , lifestyle intervention deliver via internet develop University Vermont . This successful intervention test among breast cancer survivor . Given woman tend lose muscle mass cancer therapy addition resistance training component weight loss intervention may important . Therefore overall goal project pilot test proven distantly- delivered behavioral weight loss intervention among overweight breast cancer survivor evaluate whether resistance program result improvement lean body mass , study intervention change insulin sensitivity . Specifically , project randomize , control clinical trial design test effectiveness acceptability 6-month behavioral weight loss intervention without resistance training . Participants randomize one two group : 1 ) behavioral weight control treatment via Internet ; 2 ) behavioral weight control treatment via Internet plus resistance training program . Women eligible participate include overweight breast cancer survivor age 50 old 6-36 month past receive chemotherapy . Assessments conduct baseline six month include measure body weight , muscle mass , adherence treatment , insulin sensitivity .</brief_summary>
	<brief_title>Impact Weight Loss Interventions Overweight Breast Cancer Survivors</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Overweight</mesh_term>
	<mesh_term>Weight Loss</mesh_term>
	<criteria>Postmenopausal ( last period 12 mo prior study enrollment oophorectomy ) Age 4065 DCIS , Stage I , II , III Breast Cancer BMI 2750 Completed chemotherapy treat early stage breast cancer ( Stage IIII ) less 6 month 48 month start study specific aim 3 Diagnosis DCIS Stage I breast cancer receive chemotherapy . Participant psychotic central nervous system impairment would limit compliance study requirement Evidence metastatic disease Chemotherapy cancer breast cancer Diabetes mellitus , uncontrolled hypo hyper thyroidism , liver failure Celiac sprue , inflammatory bowel disease Inability walk exercise Lymphedema indicate 2 cm circumference difference elbow weight loss previous 6 month 10 lb great</criteria>
	<gender>Female</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>breast cancer survivor</keyword>
	<keyword>weight loss</keyword>
	<keyword>postmenopausal</keyword>
	<keyword>Weight loss overweight postmenopausal breast cancer survivor</keyword>
</DOC>